Impact of Tandem Autologous/Non Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma Relapsing After a First High Dose Therapy in the Era of Novels Anti-Myeloma Agents

被引：0
|
作者：
Harel, Stephanie [1 ]
Bernard, Sophie
Chevret, Sylvie [2 ]
de Latour, Regis Peffault
Karlin, Lionel [1 ]
Robin, Marie
Ades, Lionel [3 ]
Szalat, Raphael [1 ]
Malphette, Marion [1 ]
Asli, Bouchra [1 ]
Fermand, Jean Paul [1 ]
Arnulf, Bertrand [1 ]
Socie, Gerard
机构：
[1] Hop St Louis, Dept Hematol & Immunol, Paris, France
[2] Univ Paris 07, Hop St Louis, AP HP, Paris, France
[3] Univ Paris 13, Hop Avicenne, AP HP, Dept Hematol, Paris, France
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.2035.2035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2035
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Salvage Autologous or Allogeneic Stem Cell Transplantation After the Failure of First Autograft in Patients with Multiple Myeloma.
    Bashir, Qaiser
    Thall, Peter
    Hosing, Chitra
    Mendoza, Floralyn L.
    Han, Eric
    Wang, Michael
    Shah, Jatin
    Alousi, Amin
    Anderlini, Paolo
    Kebriaei, Partow
    Khouri, Issa F.
    Popat, Uday
    de Lima, Marcos
    Champlin, Richard
    Giralt, Sergio A.
    Qazilbash, Muzaffar H.
    BLOOD, 2009, 114 (22) : 487 - 487
  • [42] Panobinostat As a Maintenance Therapy after Autologous Hematopoietic Cell Transplantation for Patients with Multiple Myeloma
    Nishihori, Taiga
    Baz, Rachid
    Ochoa, Leonel
    Puglianini, Omar Alexis Castaneda
    Shain, Kenneth H.
    Brayer, Jason B.
    Locke, Frederick L.
    Kim, Jongphil
    Song, Jinming
    Dumala, Michael
    Alsina, Melissa
    BLOOD, 2019, 134
  • [43] Phase I/II study with bendamustine hydrochloride in patients with multiple myeloma relapsing after high-dose therapy and autologous stem cell transplantation
    Knop, S
    Straka, C
    Hebart, H
    Haen, M
    Kanz, L
    Einsele, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S160 - S160
  • [44] Myeloablative allogeneic hematopoietic stem cell transplantation from unrelated donors for patients with relapsed or refractory multiple myeloma
    Tsukada, N.
    Shingaki, S.
    Ikeda, M.
    Ishida, T.
    Suzuki, K.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S466 - S467
  • [45] TANDEM AUTOLOGOUS/ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONS IN FIRST LINE HIGH RISK MULTIPLE MYELOMA PATIENTS: EVOLVING STRATEGIES WITH THE IMMUNOMODULATING DRUGS
    Michallet, M.
    Sobh, M.
    El-Cheikh, J.
    Morisset, S.
    Sirvent, A.
    Reman, O.
    Cornillon, J.
    Tabrizi, R.
    Milpied, N.
    Harousseau, J.
    Labussiere, H.
    Nicolini, F.
    Mohty, M.
    Blaise, D.
    Attal, M.
    Avet-loiseau, H.
    HAEMATOLOGICA, 2013, 98 : 98 - 98
  • [46] Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
    G Schilling
    T Hansen
    A Shimoni
    T Zabelina
    J-A Simon-Perez
    N C Gutierrez
    W Bethge
    P Liebisch
    R Schwerdtfeger
    M Bornhäuser
    S Otterstetter
    E M M Penas
    J Dierlamm
    F Ayuk
    D Atanackovic
    U Bacher
    C Bokemeyer
    A Zander
    J S Miguel
    A Nagler
    N Kröger
    Leukemia, 2008, 22 : 1250 - 1255
  • [47] Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Schilling, G.
    Hansen, T.
    Shimoni, A.
    Zabelina, T.
    Simon-Perez, J-A
    Gutierrez, N. C.
    Bethge, W.
    Liebisch, P.
    Schwerdtfeger, R.
    Bornhaeuser, M.
    Otterstetter, S.
    Penas, E. M. M.
    Dierlamm, J.
    Ayuk, F.
    Atanackovic, D.
    Bacher, U.
    Bokemeyer, C.
    Zander, A.
    Miguel, J. S.
    Nagler, A.
    Kroeger, N.
    LEUKEMIA, 2008, 22 (06) : 1250 - 1255
  • [48] Allogeneic Stem Cell Transplantation As Salvage Therapy for First Relapse after Autografting in Multiple Myeloma Patients
    Klyuchnikov, Evgeny
    Wolschke, Christine
    Badbaran, Anita
    Christopeit, Maximilian
    von Pein, Ute-Marie
    Ayuk, Francis A.
    Kroger, Nicolaus
    BLOOD, 2016, 128 (22)
  • [49] Fludarabine and anti thymocyte globulin (ATG) as a preparative regimen for non myeloablative peripheral stem cell transplantation in multiple myeloma patients relapsing post autologous transplantation.
    Kiss, TL
    Stewart, AK
    Lipton, J
    Xu, WM
    Messner, HA
    BLOOD, 1999, 94 (10) : 358B - 358B
  • [50] Superior long term progression free survival of myeloablative allogeneic hematopoietic stem cell transplantation for multiple myeloma compared to autologous hematopoietic stem cell transplantation after identical conditioning regimen
    Khaled, Yaser
    Kato, Koji
    Levine, John E.
    Mellacheruvu, Smitha
    Jakubowiak, Andrzej
    Krijanovski, Oleg
    Peres, Edward
    Reddy, Pavan
    Knott, Kevin
    Yanik, Greg
    Ferrara, James
    Mineishi, Shin
    BLOOD, 2007, 110 (11) : 890A - 890A
12345